"
Team:BostonU/Workflow
From 2014.igem.org
(Difference between revisions)
| (8 intermediate revisions not shown) | |||
| Line 14: | Line 14: | ||
<tr> | <tr> | ||
<td scope="col" colspan="2"> | <td scope="col" colspan="2"> | ||
| - | For a detailed example of our Chimera Workflow, please check out the <a href="https://2014.igem.org/Team:BostonU/ChimeraExample">Chimera Example</a> page. Below, we present a brief outline of the major steps involved in each stage (Design, Build, Test) of the Chimera workflow, along with a few high level examples. We also define what we consider Phase I, II, and III to be for our workflow. | + | <center><img src="https://static.igem.org/mediawiki/2014/1/1a/BU14_DBTcycle.png" width="40%"></center> |
| + | <br> | ||
| + | For a detailed example of our Chimera Characterization Workflow, please check out the <a href="https://2014.igem.org/Team:BostonU/ChimeraExample">Chimera Example</a> page. Below, we present a brief outline of the major steps involved in each stage (Design, Build, Test) of the Chimera workflow, along with a few high level examples. We also define what we consider Phase I, II, and III to be for our workflow. | ||
<br><br> | <br><br> | ||
| Line 58: | Line 60: | ||
• pBad_pTet<br> | • pBad_pTet<br> | ||
</p> | </p> | ||
| - | These parts were cloned into a <i>E. coli</i> Bioline strain using our MoClo and transformation protocols. They were purified | + | These parts were cloned into a <i>E. coli</i> Bioline strain using our MoClo and transformation protocols. They were purified and sequenced. Additionally, we built testing devices for each of the new parts. Details can be found on the <a href="https://2014.igem.org/Team:BostonU/FusionProteins">fusion proteins </a>, <a href="https://2014.igem.org/Team:BostonU/ProjectTandemPromoters">tandem promoters </a>, and <a href="https://2014.igem.org/Team:BostonU/Backbones">origin of replication</a> project pages. We tested these using our <a href="https://static.igem.org/mediawiki/2014/7/7c/Flow_Cytometer_WorkflowYABU.xls">FACS Workflow</a> and our BD LSRFortessa flow cytometer.The TASBE Tools were then employed to characterize their expression. |
</td> | </td> | ||
| Line 64: | Line 66: | ||
<tr> | <tr> | ||
| + | <br><br> | ||
<td scope="col" colspan="2"><h2>Phase II - Build and characterize TU behavior.</h2> | <td scope="col" colspan="2"><h2>Phase II - Build and characterize TU behavior.</h2> | ||
Key software tools: TASBE Tools, Eugene, Raven | Key software tools: TASBE Tools, Eugene, Raven | ||
| Line 81: | Line 84: | ||
<td scope="col" class="tableborderleft" style="padding-left: 15px"> | <td scope="col" class="tableborderleft" style="padding-left: 15px"> | ||
| - | • Run one-pot Multiplexing MoClo reaction. We initially multiplexed | + | • Run one-pot <a href="https://2014.igem.org/Team:BostonU/Multiplexing">Multiplexing MoClo reaction</a>. We initially multiplexed RBSs. |
<p class="tab">• Eugene was employed to visualize all possible part substitutions.<br> | <p class="tab">• Eugene was employed to visualize all possible part substitutions.<br> | ||
• Raven was employed to optimize the assembly of these combinations.</p><br><br> | • Raven was employed to optimize the assembly of these combinations.</p><br><br> | ||
| Line 90: | Line 93: | ||
<tr> | <tr> | ||
| + | <br><br> | ||
<td scope="col" colspan="2"><h2>Phase III - Test regulatory arcs and assemble final device.</h2> | <td scope="col" colspan="2"><h2>Phase III - Test regulatory arcs and assemble final device.</h2> | ||
Key software tools: TASBE Tools, Eugene, Raven | Key software tools: TASBE Tools, Eugene, Raven | ||
Latest revision as of 02:44, 18 October 2014
 For a detailed example of our Chimera Characterization Workflow, please check out the Chimera Example page. Below, we present a brief outline of the major steps involved in each stage (Design, Build, Test) of the Chimera workflow, along with a few high level examples. We also define what we consider Phase I, II, and III to be for our workflow. Phase I - Build and test basic parts.Key software tools: TASBE Tools, Eugene (optional), Raven (optional) | |
General Chimera Workflow |
Case Study: BU Priority Encoder |
 |
• Add parts to MoClo library. The following parts were found to be necessary for our priority encoder: • 3 MoClo level 1 and 3 MoClo level 2 backbones, each with a different origin of replication:
• ColE1 • 4 MoClo level 0 fusion proteins:
• tetR_GFP • X MoClo level 0 tandem promoters:
• pTet_pBad |
Phase II - Build and characterize TU behavior.Key software tools: TASBE Tools, Eugene, Raven | |
General Chimera Workflow |
Case Study: BU Priority Encoder |
 |
• Run one-pot Multiplexing MoClo reaction. We initially multiplexed RBSs.
• Eugene was employed to visualize all possible part substitutions. • Clone multiplexed reactions into Pro strain of E. coli using Pro Transformation protocol. • Pick 20 colonies per plate, purify, and sequence. • Test using flow cytometry workflow and analyze data using the TASBE Tools. |
Phase III - Test regulatory arcs and assemble final device.Key software tools: TASBE Tools, Eugene, Raven | |
General Chimera Workflow |
Case Study: BU Priority Encoder |
 |
• Test individual TU regulatory arcs • Use Eugene to plan final device topology. • Use Raven to guide MoClo assembly of encoder. • Clone multiplexed reactions into Pro strain of E. coli using Pro Transformation protocol. • Pick colonies, purify, and sequence. • Test using flow cytometry workflow and analyze data using the TASBE Tools. |
